Saudi Pharmaceutical Industries and Medical Appliances Corporation (TADAWUL:2070)
Saudi Arabia · Delayed Price · Currency is SAR 30.96
+0.16 (0.52%)
Aug 13, 2026, 3:17 PM AST
TADAWUL:2070 Cash Flow Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 214.39 | 184.36 | 24.54 | -50.73 | -165.14 | 26.45 |
Depreciation & Amortization | 81.86 | 86.85 | 78.84 | 76.19 | 84.93 | 83.66 |
Other Amortization | 10.27 | 10.27 | 5.86 | 5.82 | 3.89 | 4.44 |
Loss (Gain) From Sale of Assets | -9.86 | -28.7 | -18.94 | -6.38 | -0.14 | 0.45 |
Asset Writedown & Restructuring Costs | 3.69 | 2.68 | 17.37 | 0.05 | - | - |
Loss (Gain) From Sale of Investments | 36.55 | 21.3 | 37.06 | 42.05 | -3.63 | -7.81 |
Loss (Gain) on Equity Investments | -22.03 | -24.35 | -22.73 | -20 | -20.44 | -11.41 |
Stock-Based Compensation | 0.18 | 1.71 | 1.18 | - | - | - |
Provision & Write-off of Bad Debts | - | - | - | - | 10.05 | -13.86 |
Other Operating Activities | -12.04 | 13.16 | -73.92 | 160.41 | 11.05 | -6.84 |
Change in Accounts Receivable | -92.94 | -23.18 | -341.48 | -190.08 | 172.69 | 18.02 |
Change in Inventory | 50.67 | 25.78 | -49.6 | -143.03 | -76.56 | 13.02 |
Change in Accounts Payable | -125.51 | -59.39 | 116.37 | 128.35 | -57.96 | -14.27 |
Change in Other Net Operating Assets | 76 | 61.89 | -105.5 | 8.22 | -44.37 | -3 |
Operating Cash Flow | 202.33 | 272.35 | -330.96 | 10.87 | -99.3 | 86.71 |
Operating Cash Flow Growth | - | - | - | - | - | 790.67% |
Capital Expenditures | -88.14 | -89.14 | -71.27 | -106.79 | -78.21 | -76.24 |
Sale of Property, Plant & Equipment | 12.9 | 39.55 | 35.55 | 7.53 | 0.65 | 1.02 |
Sale (Purchase) of Intangibles | -9.29 | -10.44 | -31.01 | -5.94 | - | -1 |
Investment in Securities | 18.55 | -24.98 | -39.5 | -70.5 | 525.89 | 193.74 |
Other Investing Activities | - | - | 13.19 | 8.75 | 36.3 | 23.97 |
Investing Cash Flow | -65.98 | -85.01 | -93.05 | -166.94 | 484.63 | 141.48 |
Long-Term Debt Issued | - | 1,612 | 1,290 | 1,497 | - | 14.47 |
Long-Term Debt Repaid | - | -1,717 | -894.41 | -1,462 | -220.55 | -81.35 |
Net Debt Issued (Repaid) | -134.57 | -104.78 | 395.82 | 34.61 | -220.55 | -66.87 |
Repurchase of Common Stock | - | - | -11.94 | -8 | - | - |
Common Dividends Paid | -40.76 | - | -2.78 | -0.46 | -70.74 | -118.11 |
Other Financing Activities | -11.96 | 0.87 | - | -26.19 | -49.86 | -55.97 |
Financing Cash Flow | -187.3 | -103.91 | 381.11 | -0.04 | -341.15 | -240.95 |
Foreign Exchange Rate Adjustments | 4.09 | -1.67 | 1.95 | -16.15 | -38.5 | 8.35 |
Net Cash Flow | -46.86 | 81.76 | -40.95 | -172.26 | 5.69 | -4.42 |
Free Cash Flow | 114.2 | 183.21 | -402.23 | -95.92 | -177.51 | 10.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | 6.57% | 10.73% | -23.91% | -5.79% | -12.48% | 0.72% |
Free Cash Flow Per Share | 0.96 | 1.53 | -3.37 | -0.80 | -1.48 | 0.09 |
Levered Free Cash Flow | 47.98 | 96.42 | -353.95 | 41.76 | -121.09 | -56.73 |
Unlevered Free Cash Flow | 97.9 | 152.06 | -299.72 | 81.45 | -99.63 | -37.11 |
Cash Interest Paid | 86.53 | 72.3 | 108.15 | 69.82 | 33.41 | 20.26 |
Cash Income Tax Paid | - | - | - | - | - | 0.54 |
Change in Working Capital | -100.68 | 5.09 | -380.21 | -196.54 | -6.2 | 13.78 |